These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

9128 related items for PubMed ID: 18206104

  • 1. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J, Puech A, Boissel JP, Participants inRound Table No 7, Giens XXII.
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [Abstract] [Full Text] [Related]

  • 2. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Nov; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The NCI All Ireland Cancer Conference.
    Johnston PG, Daly PA, Liu E.
    Oncologist; 1999 Nov; 4(4):275-277. PubMed ID: 10545862
    [Abstract] [Full Text] [Related]

  • 8. [The precautionary principle: advantages and risks].
    Tubiana M.
    J Chir (Paris); 2001 Apr; 138(2):68-80. PubMed ID: 11319454
    [Abstract] [Full Text] [Related]

  • 9. Anticancer Drug Development: The Way Forward.
    Connors T.
    Oncologist; 1996 Apr; 1(3):180-181. PubMed ID: 10387985
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relative added value: what are the tools to evaluate it?
    Le Jeunne C, Woronoff-Lemsi MC, David N, de Sahb R, participants in Round Table No6, Giens XXIII.
    Therapie; 2008 Apr; 63(2):113-7, 107-11. PubMed ID: 18561884
    [Abstract] [Full Text] [Related]

  • 12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology.
    J Clin Oncol; 2003 Jun 15; 21(12):2397-406. PubMed ID: 12692171
    [Abstract] [Full Text] [Related]

  • 14. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials.
    Food Chem Toxicol; 2008 Mar 15; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [Abstract] [Full Text] [Related]

  • 15. Using routine data to complement and enhance the results of randomised controlled trials.
    Lewsey JD, Leyland AH, Murray GD, Boddy FA.
    Health Technol Assess; 2000 Mar 15; 4(22):1-55. PubMed ID: 11074392
    [Abstract] [Full Text] [Related]

  • 16. How to improve the clinical development paradigm and its division into phases I, II and III.
    Bamberger M, Moore N, Lechat P, participants of Round Table N° 3 of Giens XXVI.
    Therapie; 2011 Mar 15; 66(4):331-4, 327-30. PubMed ID: 21851796
    [Abstract] [Full Text] [Related]

  • 17. Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European level.
    Berdaï D, Hotton JM, Lechat P, participates of Round Table n° 1 Giens XXV.
    Therapie; 2010 Mar 15; 65(4):329-34. PubMed ID: 20854755
    [Abstract] [Full Text] [Related]

  • 18. [Telecommunications, health and radiology: potential synergies for the new millennium].
    Lagalla R.
    Radiol Med; 2001 Mar 15; 102(1-2):14-9. PubMed ID: 11677432
    [Abstract] [Full Text] [Related]

  • 19. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Rizzo JD.
    Best Pract Res Clin Haematol; 2005 Mar 15; 18(3):439-48. PubMed ID: 15792918
    [Abstract] [Full Text] [Related]

  • 20. New ways of insulin delivery.
    Heinemann L.
    Int J Clin Pract Suppl; 2011 Feb 15; (170):31-46. PubMed ID: 21323811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 457.